MMS22L Is a Novel Key Actor of Normal and Pathological Erythropoiesis

Whole exome sequencing of a single patient with atypical congenital pure red cell aplasia revealed a mutation in the CDAN1 gene, typically associated with congenital dyserythropoietic anemia type 1, together with a previously unreported mutation in the MMS22L gene.